$69.00
Tesamorelin is a synthetic analog of growth hormone–releasing hormone (GHRH) designed to stimulate pituitary growth hormone signaling in experimental models. It is widely referenced in endocrine and metabolic research focused on neuroendocrine regulation and peptide-based hormone signaling. Supplied strictly for laboratory research use only.
For research purposes only. Not for human consumption
Tesamorelin is structurally based on the native human GHRH(1–44) sequence with modifications that enhance stability and biological activity in research settings [1]. Preclinical and molecular studies have examined its interaction with GHRH receptors, activation of cyclic AMP signaling, and downstream effects on growth hormone release at the pituitary level [2]. Due to its peptide structure and receptor specificity, tesamorelin is frequently used as a reference compound in studies evaluating growth hormone regulation, receptor dynamics, and neuroendocrine signaling pathways [3].
In laboratory and animal research models, tesamorelin is commonly studied in endocrinology, metabolism, and body composition research frameworks. Published literature explores its role in pulsatile growth hormone secretion, insulin-like growth factor-1 (IGF-1) axis signaling, and adipose tissue metabolism under controlled experimental conditions [4]. Additional research investigates tesamorelin in hepatic lipid metabolism models and studies of visceral fat regulation at the molecular level [5][6]. These findings position tesamorelin as an important tool for researchers examining GHRH analog design, growth hormone biology, and metabolic signaling systems. This compound is not intended for human or veterinary use.
